Detalles de la búsqueda
1.
Epidemiology of Carbapenem Resistance Determinants Identified in Meropenem-Nonsusceptible Enterobacterales Collected as Part of a Global Surveillance Program, 2012 to 2017.
Antimicrob Agents Chemother
; 65(7): e0200020, 2021 06 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-33972241
2.
Longitudinal analysis of ESBL and carbapenemase carriage among Enterobacterales and Pseudomonas aeruginosa isolates collected in Europe as part of the International Network for Optimal Resistance Monitoring (INFORM) global surveillance programme, 2013-17.
J Antimicrob Chemother
; 75(5): 1165-1173, 2020 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32040168
3.
In Vitro Activity of Ceftazidime-Avibactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa Collected in Latin American Countries: Results from the INFORM Global Surveillance Program, 2012 to 2015.
Antimicrob Agents Chemother
; 63(4)2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30670424
4.
In Vitro Activity of Ceftazidime-Avibactam and Aztreonam-Avibactam against OXA-48-Carrying Enterobacteriaceae Isolated as Part of the International Network for Optimal Resistance Monitoring (INFORM) Global Surveillance Program from 2012 to 2015.
Antimicrob Agents Chemother
; 62(12)2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30249690
5.
In Vitro Activity of Ceftazidime-Avibactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa Collected in Asia-Pacific Countries: Results from the INFORM Global Surveillance Program, 2012 to 2015.
Antimicrob Agents Chemother
; 62(7)2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29760124
6.
Frequency and Mechanism of Spontaneous Resistance to Sulbactam Combined with the Novel ß-Lactamase Inhibitor ETX2514 in Clinical Isolates of Acinetobacter baumannii.
Antimicrob Agents Chemother
; 62(2)2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29133555
7.
In vitro activity of ceftazidime/avibactam against isolates of Enterobacteriaceae collected in European countries: INFORM global surveillance 2012-15.
J Antimicrob Chemother
; 73(10): 2782-2788, 2018 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30010894
8.
In vitro activity of ceftazidime/avibactam against isolates of Pseudomonas aeruginosa collected in European countries: INFORM global surveillance 2012-15.
J Antimicrob Chemother
; 73(10): 2777-2781, 2018 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30010951
9.
In Vitro Activity of Aztreonam-Avibactam against Enterobacteriaceae and Pseudomonas aeruginosa Isolated by Clinical Laboratories in 40 Countries from 2012 to 2015.
Antimicrob Agents Chemother
; 61(9)2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28630192
10.
In Vitro Susceptibility of Global Surveillance Isolates of Pseudomonas aeruginosa to Ceftazidime-Avibactam (INFORM 2012 to 2014).
Antimicrob Agents Chemother
; 60(8): 4743-9, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27216074
11.
In Vitro Susceptibility to Ceftazidime-Avibactam of Carbapenem-Nonsusceptible Enterobacteriaceae Isolates Collected during the INFORM Global Surveillance Study (2012 to 2014).
Antimicrob Agents Chemother
; 60(5): 3163-9, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26926648
12.
Global Dissemination of blaKPC into Bacterial Species beyond Klebsiella pneumoniae and In Vitro Susceptibility to Ceftazidime-Avibactam and Aztreonam-Avibactam.
Antimicrob Agents Chemother
; 60(8): 4490-500, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27161636
13.
Assessment of the In Vitro Activity of Ceftazidime-Avibactam against Multidrug-Resistant Klebsiella spp. Collected in the INFORM Global Surveillance Study, 2012 to 2014.
Antimicrob Agents Chemother
; 60(8): 4677-83, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27216054
14.
Pyridodiazepine amines are selective therapeutic agents for helicobacter pylori by suppressing growth through inhibition of glutamate racemase but are predicted to require continuous elevated levels in plasma to achieve clinical efficacy.
Antimicrob Agents Chemother
; 59(4): 2337-42, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25645840
15.
In Vitro Activity of AZD0914, a Novel Bacterial DNA Gyrase/Topoisomerase IV Inhibitor, against Clinically Relevant Gram-Positive and Fastidious Gram-Negative Pathogens.
Antimicrob Agents Chemother
; 59(10): 6053-63, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26195518
16.
A novel high-throughput cell-based assay aimed at identifying inhibitors of DNA metabolism in bacteria.
Antimicrob Agents Chemother
; 58(12): 7264-72, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25246396
17.
Discovery of inhibitors of 4'-phosphopantetheine adenylyltransferase (PPAT) to validate PPAT as a target for antibacterial therapy.
Antimicrob Agents Chemother
; 57(12): 6005-15, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24041904
18.
Exploitation of structural and regulatory diversity in glutamate racemases.
Nature
; 447(7146): 817-22, 2007 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-17568739
19.
Semimechanistic Pharmacodynamic Modeling of Aztreonam-Avibactam Combination to Understand Its Antimicrobial Activity Against Multidrug-Resistant Gram-Negative Bacteria.
CPT Pharmacometrics Syst Pharmacol
; 8(11): 815-824, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31420947
20.
ETX2514 is a broad-spectrum ß-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii.
Nat Microbiol
; 2: 17104, 2017 Jun 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-28665414